Why the study?
Bioprosthetic valve failure is a significant and debilitating sequela primarily caused by structural leaflet changes due to endocarditis, calcification, and thrombosis, but rarer causes such as metal allergy require characterization.
Allergy to a valve metal component (molybdenum) can cause bioprosthetic valve failure and may be successfully managed with immunosuppression and antihistamines.
Consider molybdenum allergy in unexplained bioprosthetic valve failure; leaves open its prevalence and testing utility.
BACKGROUND: Bioprosthetic valve failure is a significant and debilitating sequela in cardiac patients caused primarily by structural changes in valve leaflets due to endocarditis, calcification, and thrombosis. CASE SUMMARY: We describe a rare case of bioprosthetic pulmonary valve failure due to an allergic reaction to molybdenum within the valve cage. We describe the clinical presentation, clinical methods leading to the diagnosis, and treatment progression until we could resolve symptoms and a significant return of valvular competency. DISCUSSION: After excluding infectious etiologies as a cause, we used skin allergy testing to identify molybdenum as the allergic agent. The patient's symptoms and valve function improved and stabilized with immunosuppression and antihistamines. TAKE-HOME MESSAGES: Allergy to a valve metal component was diagnosed with skin allergy and treated with immunosuppression and antihistamines.
No takes yet. Share an insight, caveat, or question.
Ezekwueme et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: